table of content
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Diagnosis Overall Market Size
2.1 Global Immuno-oncology Diagnosis Market Size: 2022 VS 2030
2.2 Global Immuno-oncology Diagnosis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-oncology Diagnosis Players in Global Market
3.2 Top Global Immuno-oncology Diagnosis Companies Ranked by Revenue
3.3 Global Immuno-oncology Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Immuno-oncology Diagnosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immuno-oncology Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-oncology Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Immuno-oncology Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-oncology Diagnosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-oncology Diagnosis Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 NGS
4.1.4 Immunoassay
4.2 By Type - Global Immuno-oncology Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Diagnosis Revenue, 2018-2023
4.2.2 By Type - Global Immuno-oncology Diagnosis Revenue, 2024-2030
4.2.3 By Type - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Diagnosis Market Size, 2022 & 2030
5.1.2 Research
5.1.3 Diagnostics
5.2 By Application - Global Immuno-oncology Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Diagnosis Revenue, 2018-2023
5.2.2 By Application - Global Immuno-oncology Diagnosis Revenue, 2024-2030
5.2.3 By Application - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Immuno-oncology Diagnosis Market Size, 2022 & 2030
6.2 By Region - Global Immuno-oncology Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Diagnosis Revenue, 2018-2023
6.2.2 By Region - Global Immuno-oncology Diagnosis Revenue, 2024-2030
6.2.3 By Region - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Immuno-oncology Diagnosis Revenue, 2018-2030
6.3.2 US Immuno-oncology Diagnosis Market Size, 2018-2030
6.3.3 Canada Immuno-oncology Diagnosis Market Size, 2018-2030
6.3.4 Mexico Immuno-oncology Diagnosis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Immuno-oncology Diagnosis Revenue, 2018-2030
6.4.2 Germany Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.3 France Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.4 U.K. Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.5 Italy Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.6 Russia Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.7 Nordic Countries Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.8 Benelux Immuno-oncology Diagnosis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Immuno-oncology Diagnosis Revenue, 2018-2030
6.5.2 China Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.3 Japan Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.4 South Korea Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.5 Southeast Asia Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.6 India Immuno-oncology Diagnosis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Immuno-oncology Diagnosis Revenue, 2018-2030
6.6.2 Brazil Immuno-oncology Diagnosis Market Size, 2018-2030
6.6.3 Argentina Immuno-oncology Diagnosis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, 2018-2030
6.7.2 Turkey Immuno-oncology Diagnosis Market Size, 2018-2030
6.7.3 Israel Immuno-oncology Diagnosis Market Size, 2018-2030
6.7.4 Saudi Arabia Immuno-oncology Diagnosis Market Size, 2018-2030
6.7.5 UAE Immuno-oncology Diagnosis Market Size, 2018-2030
7 Immuno-oncology Diagnosis Companies Profiles
7.1 10x Genomics
7.1.1 10x Genomics Company Summary
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics Immuno-oncology Diagnosis Major Product Offerings
7.1.4 10x Genomics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.1.5 10x Genomics Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Immuno-oncology Diagnosis Major Product Offerings
7.2.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Abcam
7.3.1 Abcam Company Summary
7.3.2 Abcam Business Overview
7.3.3 Abcam Immuno-oncology Diagnosis Major Product Offerings
7.3.4 Abcam Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.3.5 Abcam Key News & Latest Developments
7.4 Adaptive Biotechnologies
7.4.1 Adaptive Biotechnologies Company Summary
7.4.2 Adaptive Biotechnologies Business Overview
7.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Major Product Offerings
7.4.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.4.5 Adaptive Biotechnologies Key News & Latest Developments
7.5 Aethlon Medical
7.5.1 Aethlon Medical Company Summary
7.5.2 Aethlon Medical Business Overview
7.5.3 Aethlon Medical Immuno-oncology Diagnosis Major Product Offerings
7.5.4 Aethlon Medical Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.5.5 Aethlon Medical Key News & Latest Developments
7.6 Agena Bioscience
7.6.1 Agena Bioscience Company Summary
7.6.2 Agena Bioscience Business Overview
7.6.3 Agena Bioscience Immuno-oncology Diagnosis Major Product Offerings
7.6.4 Agena Bioscience Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.6.5 Agena Bioscience Key News & Latest Developments
7.7 Angle plc
7.7.1 Angle plc Company Summary
7.7.2 Angle plc Business Overview
7.7.3 Angle plc Immuno-oncology Diagnosis Major Product Offerings
7.7.4 Angle plc Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.7.5 Angle plc Key News & Latest Developments
7.8 Apocell
7.8.1 Apocell Company Summary
7.8.2 Apocell Business Overview
7.8.3 Apocell Immuno-oncology Diagnosis Major Product Offerings
7.8.4 Apocell Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.8.5 Apocell Key News & Latest Developments
7.9 ARUP Laboratories
7.9.1 ARUP Laboratories Company Summary
7.9.2 ARUP Laboratories Business Overview
7.9.3 ARUP Laboratories Immuno-oncology Diagnosis Major Product Offerings
7.9.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.9.5 ARUP Laboratories Key News & Latest Developments
7.10 Beckman Coulter
7.10.1 Beckman Coulter Company Summary
7.10.2 Beckman Coulter Business Overview
7.10.3 Beckman Coulter Immuno-oncology Diagnosis Major Product Offerings
7.10.4 Beckman Coulter Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.10.5 Beckman Coulter Key News & Latest Developments
7.11 Becton Dickinson
7.11.1 Becton Dickinson Company Summary
7.11.2 Becton Dickinson Business Overview
7.11.3 Becton Dickinson Immuno-oncology Diagnosis Major Product Offerings
7.11.4 Becton Dickinson Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.11.5 Becton Dickinson Key News & Latest Developments
7.12 Bioarray Genetics
7.12.1 Bioarray Genetics Company Summary
7.12.2 Bioarray Genetics Business Overview
7.12.3 Bioarray Genetics Immuno-oncology Diagnosis Major Product Offerings
7.12.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.12.5 Bioarray Genetics Key News & Latest Developments
7.13 BioCartis
7.13.1 BioCartis Company Summary
7.13.2 BioCartis Business Overview
7.13.3 BioCartis Immuno-oncology Diagnosis Major Product Offerings
7.13.4 BioCartis Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.13.5 BioCartis Key News & Latest Developments
7.14 Biocept
7.14.1 Biocept Company Summary
7.14.2 Biocept Business Overview
7.14.3 Biocept Immuno-oncology Diagnosis Major Product Offerings
7.14.4 Biocept Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.14.5 Biocept Key News & Latest Developments
7.15 Biodesix Inc
7.15.1 Biodesix Inc Company Summary
7.15.2 Biodesix Inc Business Overview
7.15.3 Biodesix Inc Immuno-oncology Diagnosis Major Product Offerings
7.15.4 Biodesix Inc Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.15.5 Biodesix Inc Key News & Latest Developments
7.16 BioFluidica
7.16.1 BioFluidica Company Summary
7.16.2 BioFluidica Business Overview
7.16.3 BioFluidica Immuno-oncology Diagnosis Major Product Offerings
7.16.4 BioFluidica Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.16.5 BioFluidica Key News & Latest Developments
7.17 BioGenex 40 bioM?rieux
7.17.1 BioGenex 40 bioM?rieux Company Summary
7.17.2 BioGenex 40 bioM?rieux Business Overview
7.17.3 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Major Product Offerings
7.17.4 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.17.5 BioGenex 40 bioM?rieux Key News & Latest Developments
7.18 Bio-Rad
7.18.1 Bio-Rad Company Summary
7.18.2 Bio-Rad Business Overview
7.18.3 Bio-Rad Immuno-oncology Diagnosis Major Product Offerings
7.18.4 Bio-Rad Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.18.5 Bio-Rad Key News & Latest Developments
7.19 Bio-Techne
7.19.1 Bio-Techne Company Summary
7.19.2 Bio-Techne Business Overview
7.19.3 Bio-Techne Immuno-oncology Diagnosis Major Product Offerings
7.19.4 Bio-Techne Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.19.5 Bio-Techne Key News & Latest Developments
7.20 Bristol-Myers Squibb
7.20.1 Bristol-Myers Squibb Company Summary
7.20.2 Bristol-Myers Squibb Business Overview
7.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Major Product Offerings
7.20.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.20.5 Bristol-Myers Squibb Key News & Latest Developments
7.21 Cancer Genetics
7.21.1 Cancer Genetics Company Summary
7.21.2 Cancer Genetics Business Overview
7.21.3 Cancer Genetics Immuno-oncology Diagnosis Major Product Offerings
7.21.4 Cancer Genetics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.21.5 Cancer Genetics Key News & Latest Developments
7.22 Caris Molecular Diagnostics
7.22.1 Caris Molecular Diagnostics Company Summary
7.22.2 Caris Molecular Diagnostics Business Overview
7.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Major Product Offerings
7.22.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.22.5 Caris Molecular Diagnostics Key News & Latest Developments
7.23 CellMax Life
7.23.1 CellMax Life Company Summary
7.23.2 CellMax Life Business Overview
7.23.3 CellMax Life Immuno-oncology Diagnosis Major Product Offerings
7.23.4 CellMax Life Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.23.5 CellMax Life Key News & Latest Developments
7.24 Charles River Laboratories
7.24.1 Charles River Laboratories Company Summary
7.24.2 Charles River Laboratories Business Overview
7.24.3 Charles River Laboratories Immuno-oncology Diagnosis Major Product Offerings
7.24.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.24.5 Charles River Laboratories Key News & Latest Developments
7.25 Chronix Biomedical
7.25.1 Chronix Biomedical Company Summary
7.25.2 Chronix Biomedical Business Overview
7.25.3 Chronix Biomedical Immuno-oncology Diagnosis Major Product Offerings
7.25.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.25.5 Chronix Biomedical Key News & Latest Developments
7.26 Circulogene
7.26.1 Circulogene Company Summary
7.26.2 Circulogene Business Overview
7.26.3 Circulogene Immuno-oncology Diagnosis Major Product Offerings
7.26.4 Circulogene Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.26.5 Circulogene Key News & Latest Developments
7.27 Clearbridge BioMedics
7.27.1 Clearbridge BioMedics Company Summary
7.27.2 Clearbridge BioMedics Business Overview
7.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Major Product Offerings
7.27.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.27.5 Clearbridge BioMedics Key News & Latest Developments
7.28 Clinical Genomics
7.28.1 Clinical Genomics Company Summary
7.28.2 Clinical Genomics Business Overview
7.28.3 Clinical Genomics Immuno-oncology Diagnosis Major Product Offerings
7.28.4 Clinical Genomics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.28.5 Clinical Genomics Key News & Latest Developments
7.29 Pfizer
7.29.1 Pfizer Company Summary
7.29.2 Pfizer Business Overview
7.29.3 Pfizer Immuno-oncology Diagnosis Major Product Offerings
7.29.4 Pfizer Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.29.5 Pfizer Key News & Latest Developments
7.30 Promega
7.30.1 Promega Company Summary
7.30.2 Promega Business Overview
7.30.3 Promega Immuno-oncology Diagnosis Major Product Offerings
7.30.4 Promega Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.30.5 Promega Key News & Latest Developments
7.31 Protagen Diagnostics
7.31.1 Protagen Diagnostics Company Summary
7.31.2 Protagen Diagnostics Business Overview
7.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Major Product Offerings
7.31.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.31.5 Protagen Diagnostics Key News & Latest Developments
7.32 Qiagen
7.32.1 Qiagen Company Summary
7.32.2 Qiagen Business Overview
7.32.3 Qiagen Immuno-oncology Diagnosis Major Product Offerings
7.32.4 Qiagen Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.32.5 Qiagen Key News & Latest Developments
7.33 Quanterix
7.33.1 Quanterix Company Summary
7.33.2 Quanterix Business Overview
7.33.3 Quanterix Immuno-oncology Diagnosis Major Product Offerings
7.33.4 Quanterix Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.33.5 Quanterix Key News & Latest Developments
7.34 Rarecells SAS
7.34.1 Rarecells SAS Company Summary
7.34.2 Rarecells SAS Business Overview
7.34.3 Rarecells SAS Immuno-oncology Diagnosis Major Product Offerings
7.34.4 Rarecells SAS Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.34.5 Rarecells SAS Key News & Latest Developments
7.35 Roche Diagnostics
7.35.1 Roche Diagnostics Company Summary
7.35.2 Roche Diagnostics Business Overview
7.35.3 Roche Diagnostics Immuno-oncology Diagnosis Major Product Offerings
7.35.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.35.5 Roche Diagnostics Key News & Latest Developments
7.36 Siemens
7.36.1 Siemens Company Summary
7.36.2 Siemens Business Overview
7.36.3 Siemens Immuno-oncology Diagnosis Major Product Offerings
7.36.4 Siemens Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.36.5 Siemens Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
